Indraprastha Medical Corporation Ltd Share Price

Healthcare

NSE: INDRAMEDCO Small Cap ISIN: INE681B01017

As on 18 November 2025 at 23:52 IST

₹543.25

-4.65

(-0.85%)

Sell Buy

Over 1 Month

-1.50%

Over 6 Months

26.89%

Over 1 Year

32.71%

Over 3 Years

512.18%

Indraprastha Medical Corporation Ltd Summary

Close ₹547.90

Open ₹549.80

High ₹553.15

Low ₹544

Volume 2,12,661

Net Turnover (in Cr) ₹11.64

52Wk High ₹640.85

52Wk Low ₹307.25

52Wk High / Low

307.25

640.85

Indraprastha Medical Corporation Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹5,022.76

EPS (TTM) 19.06

Book Value (BV) 71.82

Div. Yield 0.82 %

P/E (TTM) 28.77

Price/Book Value 7.64

Delivery % 48.30 %

Face Value 10

Key Ratios

PE Ratio 21.98

PB Ratio 5.93

EV to Sales 2.40

PEG Ratio 0.74

ROA 24.40

ROE 29.97

Debt-Equity 0.06

Net Profit Margin 11.87

Operating Profit Margin 19.68

Indraprastha Medical Corporation Ltd Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

No data available

Balance Sheet

No data available

Cash Flow

Particulars (in ₹ Cr.)	FY 2011	FY 2010
Net Cash From Operating Activities	36.37	73
Net Cash Used In Investing Activities	-57.25	-36.06
Net Cash Used In Financing Activities	21.86	-35.68

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	1,379.01	1,261.59	1,108.70	891.28	614.06
Total Expenses	1,162.69	1,095.48	991.52	812.21	609.77
Profit Before Tax	216.32	166.11	117.18	79.07	4.29
Profit After Tax	160.99	123.96	86.15	58.62	2.33
Operating Profit After Depreciation	222.59	170.17	121.46	82.48	7.63

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	328.06	346.94	275.05	276.86	283.33
Total Non Current Assets	420.49	415.26	332.06	304.28	290.52
Total Current Assets	431.13	307.98	223.08	157.43	141.43
Total Assets	851.62	723.24	555.14	461.71	431.95
Total Shareholder's Fund	596.68	477.76	379.45	325.44	272.75

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	156.75	200.15	144.47	94.30	26.81
Net Cash Used In Investing Activities	-110.99	-158.43	-107.91	-74.11	-19.08
Net Cash Used In Financing Activities	-45.88	-32.38	-26.04	-3.37	-3.14

No data available

Particulars (in ₹ Cr.)	2025-09	2025-06	2025-03	2024-12	2024-09
Total Revenue	381.03	365.06	333.75	324.93	349.82
Total Expenses	309.72	291.91	272.43	272.74	286.18
Profit Before Tax	66.31	68.31	55.27	44.53	56.93
Profit After Tax	49.46	51.46	41.01	32.81	42.40
Operating Profit after Depreciation	78.68	80.05	67.67	57.32	69.69

Indraprastha Medical Corporation Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 543.55

S2 539.20

S3 534.40

Pivot 548.35

R1 552.70

R2 557.50

R3 561.85

Moving Average

20 SMA 569.67

50 SMA 525.54

100 SMA 496.30

200 SMA 450.56

Indraprastha Medical Corporation Ltd Corporate Actions

Indraprastha Medical Corporation Ltd

₹4.5/Share

Announcement Date 18 Sep 2025

Record Date 18 Sep 2025

Div Yield 45%

AGM Date: 24 Sep 2021

Indraprastha Medical Corporation Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 18 2021 to September 24 2021 (both days inclusive) for the purpose of 33rd Annual General Meeting (AGM) of the Company to be held on September 24 2021. Dear Sir Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby submit per annexure summary of the proceedings of the 33rd Annual General Meeting of the Company held on 24th September 2021 through Video Conferencing and Other Audio Visual Means. (As Per BSE Announcement Dated on 9/24/2021 1:42:47 AM) Dear Sir We wish to inform you that the 33rd Annual General Meeting (AGM) of the Company was held on 24th September 2021 through Video Conferencing and Other Audio Visual Means and the business mentioned in the Notice dated 9th August 2021 was transacted. In this regard enclosed please find the following- (1) Voting results as required under Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations - Annexure - I; and (2) Report of Scrutinizer dated 25th September 2021 pursuant to Section 108 of the Companies Act 2013 and Rule 20(4) (xii) of the Companies (Management and Administration) Rules 2014 - Annexure- II. (As Per BSE Announcement Dated on 9/25/2021 12:50:14 PM)

AGM Date: 23 Sep 2022

Approved convening the thirty-fourth Annual General Meeting (AGM) of the Company, on Friday, 23rd September, 2022, through video conferencing and other audio visual means. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit copies of the public notice of the 34th Annual General Meeting, published on 30th August, 2022, in the 'Financial Express', all India editions, in English language and in 'Jansatta', Delhi edition, in Hindi language. You are requested to take the above information on record. (As Per BSE Announcement Dated on 30/08/2022) Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit copies of the public notice of the 34th Annual General Meeting, e-voting and book closure, published on 2nd September, 2022, in the 'Financial Express', all India editions, in English language and in 'Jansatta', Delhi edition, in Hindi language. (As Per BSE Announcement dated on 02.09.2022) Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit per annexure summary of the proceedings of the 34th Annual General Meeting of the Company held on 23rd September, 2022, through Video Conferencing and Other Audio Visual Means. (As per BSE Announcement Dated on 23/9/2022) We wish to inform you that the 34th Annual General Meeting ('AGM') of the Company was held on 23rd September, 2022, through Video Conferencing and Other Audio Visual Means and the business mentioned in the Notice dated 8th August, 2022, was transacted. In this regard, enclosed please find the following- (1) Voting results as required under Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations - Annexure - I; and (2) Report of Scrutinizer dated 24th September, 2022, pursuant to Section 108 of the Companies Act, 2013 and Rule 20(4) (xii) of the Companies (Management and Administration) Rules, 2014 - Annexure- II. (As per BSE Announcement Dated on 24/9/2022)

AGM Date: 21 Sep 2023

AGM 21/09/2023 The Register of Members and Share Transfer Books of the Company shall remains closed from Saturday 16th September, 2023 to Thursday 21st September, 2023 for the purpose of AGM and Declaration of Dividend (As Per BSE Announcement dated on 04.08.2023) Pursuant to Regulation 34(1)(a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Annual Report of the Company for the financial year ended 31st March, 2023, along with the Notice of the 35th Annual General Meeting (AGM) to be held on 21st September, 2023, is attached. The said Annual Report and Notice of AGM have also been uploaded on the Company's website. Members may access the same at https://delhi.apollohospitals.com/annual-report/ (As Per BSE Announcement Dated on 28/08/2023) Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, we hereby submit copies of Public Notice for completion of dispatch of Notice of AGM and Annual Report of the 35th AGM, Remote e-voting and Book Closure, published on 29th August, 2023, in the 'Financial Express', all India editions, in English language and in 'Jansatta', Delhi edition, in Hindi language. (As Per BSE Announcement Dated on 29/08/2023) Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, we hereby submit per annexure summary of the proceedings of the 35th Annual General Meeting of the Company held on 21st September, 2023, through VC/OAVM. (As Per BSE Announcement Dated on 21/09/2023) The 35th AGM of the Company held on 21st September, 2023 through VC/OAVM. In this regard enclosed please find voting results as required under Regulation 44 of the SEBI (LODR) along with Report of Scrutinizer dated 22nd September, 2023 (As per BSE Announcement Dated on 22/09/2023)

AGM Date: 24 Sep 2024

we are enclosing herewith unaudited financial results for the quarter ended as approved by the board of directors at their meeting held today that is 05-08-2024. the board meeting ended at 5:45pm Enclosed please find we hereby submit per annexure summary of the proceedings of the 36th annual general meeting of the company held on 24th September, 2024, through Video Conferencing and Other Audio- Visual Means. Read less.. (As Per BSE Announcement Dated on 24.09.2024) we hereby submit copy of scrutinizer Report and voting result, for the AGM held on 24th September, 2024. (As Per BSE Announcement Dated on 25.09.2024)

AGM Date: 24 Sep 2025

AGM 24/09/2025 Pursuant to regulation 34(1)(a) of the Listing regulations, the Annual report of the Company for the financial year ended 31st March, 2025, along with Notice of the 37th AGM to be held on 24th September, 2025, is attached. (As Per BSE Announcement Dated on: 01/09/2025) We hereby submit per annexure summary of the proceedings of the 37th Annual general Meting of the Company held on 24th September, 2025, through Video Conferencing and Other Audio-Visual Means. (As Per BSE Announcement Dated on: 24/09/2025) the 37th AGM of the Company was held on 24th September, 2025, through Video Conferencing. In this regard, please find the following:- 1) Voting Results under Regulation 44 of the Listing Regulations; and 2) Report of Scrutinizer dated 25th September, 2025. (As Per BSE Announcement Dated on:25.09.2025)

Indraprastha Medical Corporation Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
Max Healthcare Institute Ltd	₹1,121.90	₹1,09,099.45
Apollo Hospitals Enterprise Ltd	₹7,488.40	₹1,07,671.70
Fortis Healthcare Ltd	₹944.15	₹71,279.37
Narayana Hrudayalaya Ltd	₹2,027.90	₹41,442.33
Aster DM Healthcare Ltd	₹678.35	₹35,146.74

Indraprastha Medical Corporation Ltd Top Mutal Funds Invested

Fund Name	AUM
Bandhan BSE Healthcare Index Fund	0.20%
Quant Small Cap Fund	0.14%
Motilal Oswal BSE 1000 Index Fund	0.01%

Indraprastha Medical Corporation Ltd News

Indraprastha Medical Corporation to discuss results

On 1 November 2025

17 Oct 2025, 03:49 pm

Indraprastha Medical Corporation Ltd leads gainers in 'A' group

Avalon Technologies Ltd, Shaily Engineering Plastics Ltd, RHI Magnesita India Ltd and Infibeam Avenues Ltd Partly Paidup are among the other gainers in the BSE's 'A' group today, 07 October 2025.

07 Oct 2025, 12:00 pm

Indraprastha Medical Corporation to convene AGM

On 24 September 2025

07 Aug 2025, 03:45 pm

Indraprastha Medical Corporation to conduct board meeting

On 6 August 2025

23 Jul 2025, 10:27 am

Indraprastha Medical Corporation announces cessation of director

23 May 2025, 11:06 am

Indraprastha Medical Corporation Ltd Stock Analysis

Annual revenue for Indraprastha Medical Corporation Ltd increased by 9.31% to ₹1,379.01 crore in FY 2025 from ₹1,261.59 crore in FY 2024.
Annual Net Profit for Indraprastha Medical Corporation Ltd increased by 29.87% to ₹160.99 crore in FY 2025 from ₹123.96 crore in FY 2024.
Promoter Shareholding in Indraprastha Medical Corporation Ltd remains unchanged by 0.00% in the most recent quarter, from 51% in June 2025 to 51% in September 2025.
Indraprastha Medical Corporation Ltd delivered a 1-year return of 32.71% compared to the Nifty 50, which provided a return of 10.91% as of the last trading session.
Indraprastha Medical Corporation Ltd share price moved down by 0.85% from its previous close of INR ₹547.90. The latest Indraprastha Medical Corporation Ltd share price is INR ₹543.25.
Indraprastha Medical Corporation Ltd share price today has been at a low of 534 and a high of 546.30. Over the past 52 weeks, the Indraprastha Medical Corporation Ltd share price has seen a low of 307.25 and a high of 640.85.